Indacaterol : The First Once-daily Long-acting Beta2 Agonist for COPD /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | |
| Formato: | eBook |
| Lenguaje: | English |
| Publicado: |
Basel :
Springer Basel : Imprint: Springer,
2014.
|
| Edición: | 1st ed. 2014. |
| Colección: | Milestones in Drug Therapy,
|
| Materias: |
Tabla de Contenidos:
- Current Pharmacotherapy for COPD
- The preclinical pharmacology of indacaterol
- The design of the indacaterol molecule
- The early clinical development of Indacaterol
- INHANCE: An adaptive confirmatory study with dose selection at interim
- Phase III clinical efficacy studies – lung function
- Phase III Clinical Efficacy of Indacaterol
- Patient-centered Outcomes
- The history and performance of the Breezhaler device
- What does the future hold for the therapy of COPD? .